Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2005 Publisher: Alcon Laboratories (UK) Limited, Pentagon Park, Boundary Way Hemel Hempstead, Hertfordshire, HP2 7UD, United Kingdom
VEXOL 1% (10 mg/ml) eye drops, suspension.
Pharmaceutical Form |
---|
Eye drops, suspension. Vexol is a white to off-white suspension. |
Rimexolone 10 mg/ml.
For excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Rimexolone |
Rimexolone is a corticosteroid drug. Placebo controlled clinical studies demonstrated that rimexolone is efficacious for the treatment of anterior chamber inflammation following cataract surgery. |
List of Excipients |
---|
Benzalkonium chloride |
Low density polyethylene bottles (droptainer) containing 3 mL, 5 mL, or 10 mL and with polypropylene screw caps.
Not all pack sizes may be marketed.
Alcon Laboratories (UK) Limited, Pentagon Park, Boundary Way Hemel Hempstead, Hertfordshire, HP2 7UD, United Kingdom
PL 00649/0136
19 July 1995/19th July 2000 (to be amended to 19th July 2005 on approval of MRP renewal application)
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.